Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Funds / Aegis Special Situations Fund, LLC - Series Medtech V

Aegis Special Situations Fund, LLC - Series Medtech V

UnknownSpecial situations fundADV: Private Equity FundAegis Capital Corp.Delaware
Amounts, each with its basis
Vintage
2022basis: first reported on Form ADV
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
unknownwhat may be sold, not what was raised
Form D sold
unknownno Form D on record
First sale
unknown
Reported gross assets
$11.6MForm ADV, as of Feb 29, 2024; not fund size, not dry powder
Peak reported gross assets
$11.6Mhighest year on the reporting tape
Owners (ADV)
69
Reported on ADV
Feb 28, 2022 to Feb 29, 2024
Structure
standalone
Fund of funds (ADV)
no
Strategy
Special Situations
Lifecycle
Unknown
rule: path fits no rulemodel: lc-pe-1gav path: 2022,11634212,2023,11634212,2024,11634212peak gav: $11.6Mas of year: $2,024latest gav: $11.6Mreported years: 3last step change: 0age years at as of: 2drawdown from peak: 0first reported year: $2,022
Reported gross assets by year
3 annual rows
YearFiledTypeGross assets OwnersMin. investmentNon-US ownedSource
2022Aug 17, 2022Private Equity Fund$11.6M
69$100,00060%adviserinfo.sec.gov
2023Feb 27, 2023Private Equity Fund$11.6M
69$100,00060%adviserinfo.sec.gov
2024Feb 29, 2024Private Equity Fund$11.6M
69$100,00060%adviserinfo.sec.gov
Placement agents and principals
0 placement agents, 0 principals
No placement agent or principal collected for this fund yet. Both come from the related persons and sales compensation sections of Form D.
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
1 most recent
  1. Feb 28, 2022
    Aegis Special Situations Fund, LLC - Series Medtech V first reported on Form ADV by Aegis Capital Corp. (Private Equity Fund), GAV $11,634,212